IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures.

Zeng D, Ye Z, Shen R, Yu G, Wu J, Xiong Y, Zhou R, Qiu W, Huang N, Sun L, Li X, Bin J, Liao Y, Shi M, Liao W. · 2021

Read IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures. by Zeng D, Ye Z, Shen R, Yu G, Wu J, Xiong Y, Zhou R, Qiu W, Huang N, Sun L, Li X, Bin J, Liao Y, Shi M, Liao W. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8283787.txt.

Description

Zeng and co-authors introduce IOBR, a tool for multi-omics immuno-oncology research. Sequencing advances have piled up public multi-omics datasets. Immune checkpoint drugs made tumour immune reading a clinical need.

Yet tools to read such data in full were lacking. IOBR decodes the tumour microenvironment from combined omics. It estimates immune cell makeup and extracts signatures. Those signatures link to how tumours begin and respond. The package aims at robust marks for clinical use. It gives researchers one frame for many data types. Immunotherapy sensitivity is a key target output. Signatures for therapy response are a stated aim too.

Catalog record

CREATORZeng D, Ye Z, Shen R, Yu G, Wu J, Xiong Y, Zhou R, Qiu W, Huang N, Sun L, Li X, Bin J, Liao Y, Shi M, Liao W.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE36 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC8283787

Browse the full library · About the Tower of Babel